Eyebright Medical Technology (Beijing) Co., Ltd.

XSSC:688050 Stock Report

Market Cap: CN¥17.1b

Eyebright Medical Technology (Beijing) Past Earnings Performance

Past criteria checks 2/6

Eyebright Medical Technology (Beijing) has been growing earnings at an average annual rate of 33.2%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 39% per year. Eyebright Medical Technology (Beijing)'s return on equity is 13.6%, and it has net margins of 27.2%.

Key information

33.2%

Earnings growth rate

29.8%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate39.0%
Return on equity13.6%
Net Margin27.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Eyebright Medical Technology (Beijing) makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSSC:688050 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,358370384105
30 Jun 241,23034937898
31 Mar 241,07232834593
31 Dec 2395130430992
30 Sep 2380628727685
30 Jun 2371327223979
31 Mar 2363825220572
31 Dec 2257923318764
30 Sep 2254922916859
30 Jun 2250020316056
31 Mar 2248019415754
31 Dec 2143317114852
30 Sep 2141616813748
30 Jun 2137615012240
31 Mar 2133112910736
31 Dec 20273979830
30 Sep 20237868626
30 Jun 20204688224
31 Mar 20178538423
31 Dec 19195678222
31 Dec 18127207114
31 Dec 1775-4557

Quality Earnings: 688050 has a high level of non-cash earnings.

Growing Profit Margin: 688050's current net profit margins (27.2%) are lower than last year (35.6%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 688050's earnings have grown significantly by 33.2% per year over the past 5 years.

Accelerating Growth: 688050's earnings growth over the past year (28.8%) is below its 5-year average (33.2% per year).

Earnings vs Industry: 688050 earnings growth over the past year (28.8%) exceeded the Medical Equipment industry -8.8%.


Return on Equity

High ROE: 688050's Return on Equity (13.6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies